Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions

2001 ◽  
Vol 132 (5) ◽  
pp. 682-692 ◽  
Author(s):  
Daniel E Weeks ◽  
Yvette P Conley ◽  
Hui-ju Tsai ◽  
Tammy S Mah ◽  
Philip J Rosenfeld ◽  
...  
2007 ◽  
Vol 144B (2) ◽  
pp. 193-199 ◽  
Author(s):  
M.A. Escamilla ◽  
A. Ontiveros ◽  
H. Nicolini ◽  
H. Raventos ◽  
R. Mendoza ◽  
...  

2019 ◽  
Vol 2 (1) ◽  
Author(s):  
Yoshikatsu Hosoda ◽  
Masahiro Miyake ◽  
Rosa L. Schellevis ◽  
Camiel J. F. Boon ◽  
Carel B. Hoyng ◽  
...  

AbstractThe recently emerged pachychoroid concept has changed the understanding of age-related macular degeneration (AMD), which is a major cause of blindness; recent studies attributed AMD in part to pachychoroid disease central serous chorioretinopathy (CSC), suggesting the importance of elucidating the CSC pathogenesis. Our large genome-wide association study followed by validation studies in three independent Japanese and European cohorts, consisting of 1546 CSC samples and 13,029 controls, identified two novel CSC susceptibility loci: TNFRSF10A-LOC389641 and near GATA5 (rs13278062, odds ratio = 1.35, P = 1.26 × 10−13; rs6061548, odds ratio = 1.63, P = 5.36 × 10−15). A T allele at TNFRSF10A-LOC389641 rs13278062, a risk allele for CSC, is known to be a risk allele for AMD. This study not only identified new susceptibility genes for CSC, but also improves the understanding of the pathogenesis of AMD.


The Prostate ◽  
2003 ◽  
Vol 57 (4) ◽  
pp. 280-289 ◽  
Author(s):  
Johanna Schleutker ◽  
Agnes B. Baffoe-Bonnie ◽  
Elizabeth Gillanders ◽  
Tommi Kainu ◽  
Mary-Pat Jones ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0120388 ◽  
Author(s):  
Fu-Hui Xiao ◽  
Yong-Han He ◽  
Qi-Gang Li ◽  
Huan Wu ◽  
Long-Hai Luo ◽  
...  

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 4986-4986
Author(s):  
Thai M. Cao ◽  
Wendy W. Pang ◽  
F. Carl Grumet ◽  
Laura C. Lazzeroni ◽  
Judith A. Shizuru

Abstract Minor histocompatibility antigens (mHAg) are T-cell peptide antigens derived from polymorphic endogenous gene products encoded throughout the genome. Despite extensive human genetic diversity, recent experimental evidence suggests that a mHAg set may be limited in size because alloimmune responses directed against them can be dominated by only a few specific peptides. To extend upon these observations, we performed a genome-wide scan to identify susceptibility loci for graft-versus-host disease (GVHD) in a murine model. We previously identified B10.BR (H2k) mice to be resistant, and BALB.K (H2k) mice susceptible, to lethal GVHD when transplanted with hematopoietic cells from MHC-matched AKR/J (H2k) donors (Cao et al. PNAS2003:11571). In the present study B10.BR, BALB.K, or (B10.BR x BALB.K)F1 mice were lethally irradiated and injected with AKR/J bone marrow at radioprotective doses plus 2.0 or 3.0 x 106 purified splenic T-cells. Confirming our prior observations, B10.BR mice survived to day 60 whereas all BALB.K mice died prior to day 10 from GVHD. All (B10.BR x BALB.K)F1 mice also died after a median of 10 days, indicating that GVHD susceptibility in BALB.K mice is a dominant trait. (B10.BR x BALB.K)F1 mice were then backcrossed to the GVHD-resistant B10.BR parent. Resulting [B10.BR x (B10.BR x BALB.K)]BC mice (n = 180) were genotyped and similarly irradiated and injected with AKR/J bone marrow plus 3.0 x 106 splenic T-cells. Forty (22%) BC mice died with signs of GVHD prior to day 100. Surprisingly, a 90-marker genome-wide scan for this phenotype, lethal GVHD prior to day 100, revealed highly significant linkage (P <.001) only to chromosome 16. Linkage analysis was performed with MapManager QTX 0.29 using Kosambi’s map function. As shown in Figure 1, interval mapping for chromosome 16 with additional markers revealed a broad and complex linkage pattern encompassing 2 markers, D16Mit4 (27.3 cM) and D16Mit189 (55.2 cM), that had peak LOD scores of 8.8 and 8.0 respectively. Another genetic locus on chromosome 13 flanked by markers D13Mit248 and D13Mit149 with a peak LOD score of 2.3 by interval mapping was suggestively linked. While an evaluation of candidate genes within the support intervals is in progress, these results thus far suggest that the critical gene dose required for inducing lethal GVHD may be remarkably small. If validated as encoding for immunodominant mHAg, these results furthermore suggest that a functionally relevant mHAg set may be definable for clinical genotyping.


PLoS Genetics ◽  
2015 ◽  
Vol 11 (12) ◽  
pp. e1005728 ◽  
Author(s):  
Kristen Fortney ◽  
Edgar Dobriban ◽  
Paolo Garagnani ◽  
Chiara Pirazzini ◽  
Daniela Monti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document